PMID- 36684235 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20230201 IS - 2296-875X (Print) IS - 2296-875X (Electronic) IS - 2296-875X (Linking) VI - 9 DP - 2022 TI - The predictive value of revised diastolic dysfunction in outcomes of liver transplantation: A propensity score matching analysis. PG - 1072908 LID - 10.3389/fsurg.2022.1072908 [doi] LID - 1072908 AB - BACKGROUND: Diastolic dysfunction (DD), one of the earliest signs of cirrhotic cardiomyopathy (CCM), is included in the revised 2019 CCM criteria. Nonetheless, relevant research regarding the effects of revised DD on post-liver transplantation (LT) outcomes remains limited. METHODS: This retrospective study enrolled patients who underwent LT for decompensated cirrhosis, from January 2018 to March 2021. Patients were divided into DD and non-DD groups. Clinical data were collected. Patients were followed up with, for at least 1 year post-LT; cardiovascular adverse events (AEs) and survival status were recorded. Risk factors were identified using 1:2 propensity score matching (PSM), after adjusting for confounding factors. The caliper value was set to 0.02. RESULTS: Of 231 patients, 153 were diagnosed with DD (male, 81.8%; mean age, 51.5 +/- 9.5 years). Nineteen patients with DD died within 1 year, post-LT. After PSM, 97 and 60 patients were diagnosed with and without DD, respectively. Patients with DD had longer intensive care unit (ICU) stays, higher perioperative cardiovascular AEs, and higher mortality rates than those without DD. In a multivariate analysis, interventricular septum (IVS), left atrial volume index (LAVI), and potassium levels were independent prognostic factors of perioperative cardiovascular AEs, while a decreased early diastolic mitral annular tissue velocity (e'), increased neutrophil-to-lymphocyte ratio (NLR) and tumor markers were predictors of mortality within 1 year post-LT after PSM (P < 0.05). CONCLUSION: Cardiac DD may contribute to perioperative cardiovascular AEs and mortality post-LT. Clinicians should be aware of decompensated cirrhosis in patients with DD. CI - (c) 2023 Bi, Jiang, Zhao, Niu, Liu and Jing. FAU - Bi, Shenghua AU - Bi S AD - Gastroenterology Department, The Affiliated Hospital of Qingdao University, Qingdao, China. FAU - Jiang, Yueping AU - Jiang Y AD - Gastroenterology Department, The Affiliated Hospital of Qingdao University, Qingdao, China. FAU - Zhao, Wenjun AU - Zhao W AD - Gastroenterology Department, The Affiliated Hospital of Qingdao University, Qingdao, China. FAU - Niu, Xiaoyan AU - Niu X AD - Department of Ultrasound, The Affiliated Hospital of Qingdao University, Qingdao, China. FAU - Liu, Xuechun AU - Liu X AD - Gastroenterology Department, The Affiliated Hospital of Qingdao University, Qingdao, China. FAU - Jing, Xue AU - Jing X AD - Gastroenterology Department, The Affiliated Hospital of Qingdao University, Qingdao, China. LA - eng PT - Journal Article DEP - 20230106 PL - Switzerland TA - Front Surg JT - Frontiers in surgery JID - 101645127 PMC - PMC9852983 OTO - NOTNLM OT - adverse events OT - cirrhotic cardiomyopathy OT - decompensated cirrhosis OT - liver transplantation OT - mortality COIS- The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. EDAT- 2023/01/24 06:00 MHDA- 2023/01/24 06:01 PMCR- 2023/01/06 CRDT- 2023/01/23 04:21 PHST- 2022/10/18 00:00 [received] PHST- 2022/12/12 00:00 [accepted] PHST- 2023/01/23 04:21 [entrez] PHST- 2023/01/24 06:00 [pubmed] PHST- 2023/01/24 06:01 [medline] PHST- 2023/01/06 00:00 [pmc-release] AID - 10.3389/fsurg.2022.1072908 [doi] PST - epublish SO - Front Surg. 2023 Jan 6;9:1072908. doi: 10.3389/fsurg.2022.1072908. eCollection 2022.